Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2014, Article ID 478983, 6 pages
http://dx.doi.org/10.1155/2014/478983
Research Article

Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial

1Harvard Radiation Oncology Program, Harvard Medical School, 75 Francis Street, L2, Boston, MA 02115, USA
2Department of Statistics, University of Connecticut, 215 Glenbrook Road, U-4120, Storrs, CT 06269, USA
3Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, 75 Francis Street, L2, Boston, MA 02115, USA

Received 21 October 2013; Accepted 6 January 2014; Published 13 February 2014

Academic Editor: David K. Ornstein

Copyright © 2014 Ravi A. Chandra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Cancer Facts & Figures, American Cancer Society, Atlanta, Ga, USA, 2013.
  2. C. L. Ogden, M. D. Carroll, B. K. Kit, and K. M. Flegal, “Prevalence of obesity in the United States, 2009-2010,” NCHS Data Brief, no. 82, pp. 1–8, 2012. View at Google Scholar
  3. R. K. Masters, E. N. Reither, D. A. Powers et al., “The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates,” American Journal of Public Health, vol. 103, no. 10, pp. 1895–1901, 2013. View at Google Scholar
  4. C. Haggstrom, T. Stocks, D. Ulmert et al., “Prospective study on metabolic factors and risk of prostate cancer,” Cancer, vol. 118, no. 24, pp. 6199–6206, 2012. View at Google Scholar
  5. J. Ma, H. Li, E. Giovannucci et al., “Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis,” The Lancet Oncology, vol. 9, no. 11, pp. 1039–1047, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Freedland, W. J. Aronson, C. J. Kane et al., “Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the shared equal access regional cancer hospital database study group,” Journal of Clinical Oncology, vol. 22, no. 3, pp. 446–453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. C. L. Amling, R. H. Riffenburgh, L. Sun et al., “Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy,” Journal of Clinical Oncology, vol. 22, no. 3, pp. 439–445, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. S. S. Strom, A. M. Kamat, S. K. Gruschkus et al., “Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer,” Cancer, vol. 107, no. 3, pp. 631–639, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Efstathiou, M.-H. Chen, A. A. Renshaw, M. J. Loffredo, and A. V. D'Amico, “Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer,” Cancer, vol. 109, no. 8, pp. 1493–1498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Zilli, M. Chagnon, T. Van Nguyen et al., “Influence of abdominal adiposity, waist circumference, and body mass index on clinical and pathologic findings in patients treated with radiotherapy for localized prostate cancer,” Cancer, vol. 116, no. 24, pp. 5650–5658, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Parker, D. D. Thiel, E. Bergstralh et al., “Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies,” Prostate Cancer and Prostatic Diseases, vol. 16, no. 4, pp. 352–356, 2013. View at Publisher · View at Google Scholar
  12. E. Kheterpal, J. D. Sammon, M. Diaz et al., “Effect of metabolic syndrome on pathologic features of prostate cancer,” Urologic Oncology, vol. 31, no. 8, pp. 1054–1059, 2013. View at Google Scholar
  13. C. J. Keto, W. J. Aronson, M. K. Terris et al., “Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database,” BJU International, vol. 110, no. 4, pp. 492–498, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. De Nunzio, S. Albisinni, S. J. Freedland et al., “Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: a prospective multicenter Italian cohort study,” Urologic Oncology, vol. 31, no. 7, pp. 997–1002, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Venkateswaran, A. Q. Haddad, N. E. Fleshner et al., “Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts,” Journal of the National Cancer Institute, vol. 99, no. 23, pp. 1793–1800, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Caso, E. M. Masko, J. A. Ii et al., “The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model,” Prostate, vol. 73, no. 5, pp. 449–454, 2013. View at Google Scholar
  17. T. Schnoeller, F. Jentzmik, L. Rinnab et al., “Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer,” World Journal of Urology, vol. 31, no. 2, pp. 253–259, 2013. View at Google Scholar
  18. G. Williams, “Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling,” Molecular and Cellular Endocrinology, vol. 351, no. 2, pp. 269–278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Okamoto, C. Lee, and R. Oyasu, “Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro,” Cancer Research, vol. 57, no. 1, pp. 141–146, 1997. View at Google Scholar · View at Scopus
  20. P. L. Nguyen, J. Ma, J. E. Chavarro et al., “Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival,” Journal of Clinical Oncology, vol. 28, no. 25, pp. 3958–3964, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. F. Piccirillo, R. M. Tierney, I. Costas, L. Grove, and E. L. Spitznagel Jr., “Prognostic importance of comorbidity in a hospital-based cancer registry,” Journal of the American Medical Association, vol. 291, no. 20, pp. 2441–2447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. V. D'Amico, M.-H. Chen, A. A. Renshaw, M. Loffredo, and P. W. Kantoff, “Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial,” Journal of the American Medical Association, vol. 299, no. 3, pp. 289–295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. P. Klein and M. L. Moeschberger, “Semiparametric proportional hazards regression with fixed covariates,” in Survival Analysis: Techniques for Censored and Truncated Data, J. P. Klein and M. L. Moeschberger, Eds., pp. 243–293, Springer, New York, NY, USA, 2nd edition, 2003. View at Google Scholar
  24. E. L. Kaplan and P. Meier, “Non-parametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, pp. 457–481, 1958. View at Google Scholar
  25. R. J. Gray, “A class of K-sample tests for comparing the cumulative incidence of a competing risk,” Annals of Statistics, vol. 16, pp. 1141–1154, 1988. View at Google Scholar
  26. “Simultaneous inferences and other topics in regression analyses-1,” in Applied Linear Regression Models, J. Neter, W. Wassermann, and M. Kutner, Eds., pp. 150–153, Richard D Irwin, Homewood, Ill, USA, 1983.
  27. E. H. Allott, E. M. Masko, and S. J. Freedland, “Obesity and prostate cancer: weighing the evidence,” European Urology, vol. 63, pp. 800–809, 2013. View at Google Scholar
  28. National Institutes of Health, “Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report,” Obesity Research, vol. 6, article 464, 1998. View at Google Scholar
  29. M. H. Murphy, A. M. Nevill, E. M. Murtagh, and R. L. Holder, “The effect of walking on fitness, fatness and resting blood pressure: a meta-analysis of randomised, controlled trials,” Preventive Medicine, vol. 44, no. 5, pp. 377–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. V. D'Amico, R. Whittington, S. B. Malkowicz et al., “Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer,” Journal of the American Medical Association, vol. 280, no. 11, pp. 969–974, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. N. L. Keating, A. J. O'Malley, and M. R. Smith, “Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer,” Journal of Clinical Oncology, vol. 24, no. 27, pp. 4448–4456, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Braga-Basaria, A. S. Dobs, D. C. Muller et al., “Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy,” Journal of Clinical Oncology, vol. 24, no. 24, pp. 3979–3983, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. L. E. Millender, M. Aubin, J. Pouliot, K. Shinohara, and M. Roach III, “Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 59, no. 1, pp. 6–10, 2004. View at Publisher · View at Google Scholar · View at Scopus